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ABSTRACT 
Peganum harmala L. (Zygophyllaceae) is one of the most famous medicinal plants used in 
traditional medicine of Iran. The aim of this study was to consider antibacterial effects of the 
methanolic extract of different parts of P. harmala including root, stem, leaf, flower and seed 
against some important human pathogenic bacteria. Antibacterial properties of methanolic 
extract of mentioned parts were assessed by disc diffusion method. Active extract was frac-
tioned using Thin Layer Chromatography; also their synergism activity in combination with 
synthetic antibiotic was evaluated. Among the evaluated parts of P. harmala, the root and 
seed extracts presented antibacterial activity against all of tested bacteria even at the lowest 
concentration. Antibacterial effect of leaf part was moderate while stem and flower extracts 
showed relatively poor activity. Antibacterial activity of root extract against most of the tested 
Gram positive bacteria was better than seed extract. Tested against Gram negative bacteria the 
obtained results were inconsistent. MIC (Minimal Inhibitory Concentration) and MBC 
(Minimal Bactericidal Concentration) values for both extracts against MRSA (Methicillin Re-
sistant Staphylococcus aureus) and for seed extract against E. coli and S. typhi were equal 
(0.625 mg/ml). TLC (Thin Layer Chromatography) results revealed that seed and root extracts 
were different in terms of nature and content of their constituents. Furthermore, these two ex-
tracts showed an excellent stability to temperature and pH treatment. Also, the seed and root 
extracts showed synergism in combination with novobiocin, colistin and carbenicillin. In con-
clusion, P. harmala can be assigned as a source of antibacterial compounds for treatment of 
infections caused by multi-drug resistant (MDR) bacterial pathogens. 
 
Keywords: antibiotic resistance, medicinal plants, Peganum harmala, E. coli, S. aureus,  
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INTRODUCTION 
Nowadays, bacterial infections espe-
cially those caused by multi-drug resistant 
(MDR) bacteria have become one of the 
great challenges for modern healthcare. 
Therefore, discovering new antibacterial 
compounds with improved activity is nec-
essary. Majority of scientists define multi-
drug resistance (MDR) as ˝resistance to at 
least 3 classes of antimicrobial agents˝ 
(Falagas et al., 2006). Since the ancient 
time, the idea of finding healing powers in 
plants has been noteworthy. Plants produce 
a vast array of secondary metabolites that in 
many cases, these substances act as defense 
mechanisms against predation by herbi-
vores, microorganisms and insects; also 
similar substances can be produced by 
plants as a part of their normal growth and 
development or in response to stress (Mir-
jana et al., 2004; Cowan, 1999). Peganum 
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harmala L. (Zygophyllaceae), that is also 
called Harmal, Suryin Rue, is a perennial, 
bushy, and wild-growing flowering plant 
with short creeping root which may grow to 
30-100 cm high (Shamsa et al., 2007; Goel 
et al., 2009; Mahmoodian et al., 2002) is 
known as “Espand’’ in Iran and Harmal in 
North Africa and African Rue, Mexican 
Rue, Syrian Rue or Turkish Rue in United 
States (Mahmoodian et al., 2002). It’s na-
tive to semi-arid rangeland, steppe area and 
sandy soils (Mahmoodian et al., 2002). This 
plant is widely distributed in North Africa, 
Mediterranean, the Middle East, Pakistan, 
India and Iran and has been introduced in 
America and Australia (Asghari and Lock-
wood, 2002; Ehsanpour and Saadat, 2002; 
Yousefi et al., 2009). P. harmala tradition-
ally has been used in Iran as an antiseptic 
and disinfectant agent by burning its seeds 
(Fathiazada et al., 2006; Arshad et al., 
2008). This plant has been considered for 
the treatment of a variety of human ail-
ments, such as lumbago, asthma, colic, 
jaundice and as a stimulant emmenagogue 
(Bukhari et al., 2008). The most pharma-
cological active compounds of P. harmala 
are several alkaloids which are found in the 
seeds and roots (Mirzaie et al., 2007). There 
are various reports that P. harmala had dif-
ferent pharmacological activities including 
spontaneous effect (Fathiazada et al., 2006), 
anti-tumor effect (Goel et al., 2009), insec-
ticidal effect (Goel et al., 2009), caving ma-
laria (Goel et al., 2009), anti-leishmanial 
(Mirzaie et al., 2007), anti-spasmodic (As-
ghari and Lockwood, 2002), anti-histaminic 
(Asghari and Lockwood, 2002), vasorelax-
ant effect (Asghari and Lockwood, 2002), 
wound healing (Derakhshanfar et al., 2009), 
anti-oxidant activity (Astulla et al., 2008), 
leukemic healing (Zaker et al., 2007), hy-
poglycemic effect (Singh et al., 2008), im-
muno-modulator properties (Astulla et al. 
2008), analgesic and anti-inflammatory 
properties (Muhi-eldeen et al., 2008). Also, 
it has been reported that this plant had anti-
bacterial, antifungal and antiviral effects 
(Shonoudam et al., 2008); this study fo-
cused on the seed extract of P. harmala. 
However, a study with focusing on antibac-
terial activity of different parts of P. har-
mala has not yet been documented. The ob-
jective of the present study was to assess 
the antibacterial property of the methanol 
extract from different parts of P. harmala 
including flower, seed, leave, stem and root 
against some most important human patho-
genic bacteria.  
 
MATERIALS AND METHODS 
Plant material collection and identifica-
tion 
Different parts of P. harmala were col-
lected from hills around Behbahan (south 
east of Khuzestan province, Iran) in 2009. 
Sample collection was done in April for 
leave and stem, in May for flower, in June 
for seed and in September for root. The 
plant used in this study was taxonomically 
identified by the Herbarium of Agricultural 
Science Faculty, Shahid Chamran Univer-
sity, Ahvaz, Iran. Voucher specimens were 
deposited at the Department of Biology, 
Shahid Chamran University, Iran. 
 
Preparation of extract 
The leaf, flower, seed and stem were 
shade dried at room temperature for ten 
days while the root was shade dried for 
twenty days. These mentioned parts were 
ground to a fine powder. The powder (1 g) 
was extracted using 10 ml of methanol-
distilled water solution (8:2 v/v), centri-
fuged at 3000 rpm for 15 min and collect-
ing the supernatant. This process was re-
peated for three times. Then, solvent re-
moved by evaporation (Darabpour et al., 
2010). 
 
Tested microorganisms 
A total of thirteen bacteria were selected 
for this study. Gram positive bacterial spe-
cies were Bacillus anthracis, Bacillus cer-
eus, Bacillus pumilus, Staphylococcus 
aureus, Staphylococcus epidermidis, Lis-
teria monocytogenes and Streptococcus 
pyogenes. Gram negative bacterial species 
were Pseudomonas aeruginosa, Brucella 
melitensis, Proteus mirabilis, Salmonella 
typhi, Escherichia coli and Klebsiella pneu-
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moniae. These species were originally iso-
lated from clinical specimens and identified 
by standard biochemical reactions based on 
morphological and biochemical characters 
according to the methods described in Ber-
gey’s manual for systematic bacteriology 
(Garrity et al., 2006). Different characteris-
tics were Gram stain, pigmentation, motility 
and utilization of different carbon and ni-
trogen sources and so on. 
 
Inoculums preparation for antibacterial 
assay 
All of the tested bacteria were cultured 
over night at 37 °C in the Muller-Hinton 
Broth (MHB, Merck) and used as inocu-
lums. The turbidimetry of the suspension 
was adjusted to the McFarland 0.5 turbidity 
standard (108 cfu/ml) (Owen and Palombo, 
2007; Chomnawang et al., 2005). 
 
Antibacterial assay procedure 
At first, a total of 0.1 ml of bacterial 
suspension was poured on each plate con-
taining Muller-Hinton Agar (MHA, 
Merck). The lawn culture was prepared by 
sterile cotton swab and allowed to remain in 
contact for 1 min. Four concentrations of 
methanolic extracts (50, 100, 200, and 
400 mg/ml) from each of the used parts of 
P. harmala were prepared. The sterile filter 
paper discs (6 mm diameter) (Cermelli et 
al., 2008) were saturated by 35 µl of differ-
ent concentrations of each extract and then 
were placed on lawn cultures. The Petri 
dishes were subsequently incubated at 
37 °C for 24 h and the inhibition zone 
around each disc was measured in mm. 
This experiment was carried out in dupli-
cate. As positive controls, discs containing 
novobiocin 30 µg, nalidixic acid 30 µg, car-
benicillin 100 µg, colistin 10 µg, strepto-
mycin 10 µg and methicillin 5 µg were 
used. All of these synthetic antibiotic discs 
were prepared from Difco. Discs impreg-
nated with 80 % and methanol was also in-
cluded to test if they had an inhibitory ef-
fect on the test bacteria. 
 
MIC and MBC determination 
The MIC (Minimal Inhibitory Concen-
tration) and MBC (Minimal Bactericidal 
Concentration) of methanolic extracts from 
the most effective parts of P. harmala were 
determined against somewhat important 
and more sensitive bacteria. MIC was de-
termined by the macro broth dilution assay 
method (NCCLS, 2008; Motamedi et al., 
2010). In the tube dilution assay, standard 
bacterial suspension and different concen-
trations of extract (0.312, 0.625, 1.25, 2.5, 
5, 10, 20, 40, 80, 160, and 200 mg/ml) were 
added to tubes containing 1 ml Muller-
Hinton Broth (MHB, Merck). These tubes 
were incubated at 37 °C for 24 h. The first 
tube in the above series without sign of vis-
ible growth was considered as the MIC. 
MBC was determined by culturing one 
standard loop of the tubes with no apparent 
growth on MHA and subsequent incubation 
at 37 °C for 24 h. The least concentration 
that inhibited colony formation on agar was 
considered as MBC for the extract. 
 
Study of the synergistic effect 
To determine the synergistic effect of 
the most effective parts of P. harmala with 
synthetic antibiotics, 400 mg/ml concentra-
tion of their extract was added to the discs 
containing these antibiotics (novobiocin, 
colistin and carbenicillin) and their effect 
was evaluated by disc diffusion method on 
the most important bacterial pathogens 
among tested bacteria (Motamedi et al., 
2010). 
 
Physicochemical treatment of the active 
extracts 
To find out thermostability of antibacte-
rial compound, 1 ml aliquots of the most 
effective parts extract at 100 mg/ml concen-
tration were added to the sterile screw 
capped ampoules and treated by tempera-
ture at 4 °C in refrigerator for 24 h and 25, 
37, 56, 70 and 90 °C in a water bath for 30 
min (Salama and Marraiki, 2009; Amin et 
al., 2010). To determine the effect of pH, 
the methanolic extract of the most effective 
parts at 100 mg/ml concentration were 
treated at pH ranges from 2 to 10 using ei-
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ther 1N HCl or 1N NaOH solutions for 
30 min at 4 °C (Salama and Marraiki, 
2009). Finally, the result of these treatments 
was found by measurement of the inhibition 
zone against one of the most important hu-
man pathogenic bacterium. 
 
Fractionation of the most effective extract 
by Thin Layer Chromatography (TLC)  
The methanolic extracts of the most ef-
fective parts of P. harmala were analyzed 
by TLC; the presence of different constitu-
ent types in screened extracts was estab-
lished by adding 15 µl of extracts at 
100 mg/ml concentration on silica gel plate 
(Merck 60 F254 10-20 cm), the plate was 
developed in a chamber saturated with sol-
vent system n-butanol: acetic acid: distilled 
water (v/v 4:4:1) as mobile phases. The 
separated components were visualized un-
der visible and ultraviolet light (254 and 
366 nm). Also, the retardation factor (Rf) 
values of the spots were determined.  
 
RESULTS 
On the basis of the obtained results that 
are shown in Figures 1-5, the seed and root 
extracts of P. harmala have a broad anti-
bacterial activity so that all of the tested 
clinical bacteria were sensitive to these two 
extracts while flower, leaf and stem were 
presented a relatively poor antibacterial ac-
tivity. Increasing the antibacterial activity 
of the different parts of P. harmala was ob-
served at higher concentrations. Among 
Gram positive bacteria, S. epidermidis and 
Str. pyogenes were the most sensitive 
strains to the seed and root extracts while 
among Gram negative bacteria, K. pneumo-
niae and Br. melitensis had the most sensi-
tivity to the seed extract and K. pneumoniae 
and E. coli to the root extract too. P. mir-
abilis and P. aeruginosa were the most re-
sistant strains to these two extracts. Anti-
bacterial activity of the root extract against 
tested Bacillus species and S. aureus was 
better than the seed extract. Moreover, the 
seed extract of P. harmala was more effec-
tive than the root extract against Gram neg-
ative bacteria. The flower, leaf and stem 
extracts of P. harmala showed inhibitory 
effect against S. epidermidis, Str. pyogenes 
and B. anthracis at the highest concentra-
tion. Among the used parts of P. harmala, 
the flower extract showed the least antibac-
terial activity. All of the tested clinical bac-
teria were MDR strains. E. coli, P. aerugi-
nosa, S. typhi and L. monocytogenes were 
the most resistant strains to the synthetic 
antibiotics (Figure 6). Tested S. aureus ex-
hibited resistance to methicillin. Also, all of 
the tested bacteria were resistant to colistin. 
Considering antibacterial activity of the dif-
ferent parts of P. harmala, seed and root 
extracts were chosen for further study. 
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Figure 1: Antibacterial activity of seed extract of P. harmala against some clinical bacterial pathogens.  
*: The diameter of disc is 6 mm. 
(Se E): Seed extract 
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Figure 2: Antibacterial activity of leaf extract of P. harmala against some clinical bacterial pathogens.  
*: The diameter of disc is 6 mm. 
(L E): Leaf extract 
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Figure 3: Antibacterial activity of flower extract of P. harmala against some clinical bacterial pathogens.  
*: The diameter of disc is 6 mm. 
 
0
3
6
9
12
15
18
In
hi
bi
ti
on
 Z
on
e 
(m
m
)
*
B.c
er
eu
s
B.a
nt
hr
ac
is
B.p
um
ilu
s
S.a
ur
eu
s
S.e
pid
er
m
idi
s
L.m
on
oc
yto
ge
ne
s
Str
. P
yo
ge
ne
s
P.a
er
ug
ino
sa
E.c
oli
P.m
ira
bil
is
Br
.m
eli
te
ns
is
K.p
ne
um
on
iae
S.t
yp
hi
Bacterial Species 
50 mg/mL (St E)
100 mg/mL (St E) 
200 mg/mL (St E) 
400 mg/mL (St E) 
 
 
Figure 4: Antibacterial activity of stem extract of P. harmala against some clinical bacterial pathogens.  
*: The diameter of disc is 6 mm. 
(St E): Stem extract 
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Figure 5: Antibacterial activity of root extract of P. harmala against some clinical bacterial pathogens.  
*: The diameter of disc is 6 mm. 
(R E): Root extract 
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Figure 6: Antibacterial activity of synthetic antibiotics against some clinical bacterial pathogens.  
*: The diameter of disc is 6 mm. 
 
 
Results of MIC and MBC determination 
(Table 1) showed that MIC and MBC val-
ues for the seed and root extract of P. har-
mala against MRSA are equal (0.625 mg/ 
ml). Also, these values for seed extract 
against E. coli and S. typhi were the same 
(0.625 mg/ml) while for the root extract 
were different. Moreover, MIC values for 
seed and root extracts against B. anthracis 
were 2.5 and 1.25 mg/ml, respectively 
while MBC values were 5 and 2.5 mg/ml, 
respectively.  
 
 
Table 1: The MIC and MBC values of seed and 
root extracts of P. harmala against some impor-
tant bacterial pathogens 
 
Part 
used 
Bacterial 
species 
MIC 
(mg/ml) 
MBC 
(mg/ml) 
Seed MRSA 0.625 0.625 
Root MRSA 0.625 0.625 
Seed B. anthracis 2.5 5 
Root B. anthracis 1.25 2.5 
Seed E. coli 0.625 0.625 
Root E. coli 0.625 1.25 
Seed S. typhi 0.625 0.625 
Root S. typhi 0.625 1.25 
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Based on the results from pH treatment 
(Figure 7), the best activity of the seed ex-
tract was observed at the pH ranges from 4 
to 7 while for root extract was in pH 6 and 
7. The observed zone of inhibition after 
treatment of the seed extract with the dif-
ferent temperature was equal to untreated 
extract (20 mm) (Figure 8) but, antibacterial 
activity of the root extract partially was af-
fected when treated at 70 and 90 °C. In 
general, antibacterial activity of these two 
extracts was not considerably affected after 
temperature and pH treatment. 
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Figure 7: Results of pH stability treatment of  
P. harmala seed and root extracts 
DIZ (S): Diameter of Inhibition Zone for Seed 
Extract against MRSA 
DIZ (R): Diameter of Inhibition Zone for Root 
Extract against MRSA 
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DIZ (R) 20 20 20 20 19 19
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Figure 8: Results of the temperature treatment 
on P. harmala seed and root extracts.  
DIZ (S): Diameter of Inhibition Zone for Seed 
Extract against MRSA  
DIZ (R): Diameter of Inhibition Zone for Root 
Extract against MRSA  
As we can see in Figures 9A and B and 
Table 2, there are spots (at 254 and 336 nm) 
with different Rf values or molecular 
weight in seed and root extracts of P. har-
mala. Some spots are more intensive in one 
extract comparing with other extract. In 
general, the obtained results from TLC re-
vealed that these two parts of P. harmala 
have several different constituents. 
 
 
      (A1)       (A2)                      (B1)        (B2) 
(A)                                      (B) 
Figure 9: TLC analysis for P. harmala seed and 
root extracts.  
A: TLC plate visualized at 254 nm 
B: TLC plate visualized at 366 nm 
A1 and B1: Seed extract 
A2 and B2: Root extract 
 
Table 2: Rf values of the obtained spots (at 
336 nm): From high molecular weight to low 
molecular weight 
Spot Rf Spot Rf 
B1b1 0/19 B2b1 0/14 
B1b2 0/34 B2b2 0/17 
B1b3 0/45 B2b3 0/31 
B1b4 0/53 B2b4 0/38 
B1b5 0/59 B2b5 0/51 
B1b6 0/72 B2b6 0/59 
B1b7 0/88 B2b7 0/74 
B1b8 0/93 B2b8 0/88 
- - B2b9 0/93 
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The results of the combination of seed 
and root extracts of P. harmala with novo-
biocin, colistin and carbenicillin showed 
that these combinations have synergistic 
effect against tested bacteria (Table 3). 
Combination of seed and root extract with 
novobiocin against E. coli, B. anthracis, K. 
pneumoniae and MRSA showed a remark-
able synergistic effect. Although E. coli and 
L. monocytogenes were resistant to colistin, 
the combination of this synthetic antibiotic 
with seed and root extract showed excellent 
antibacterial activity against these two bac-
teria. Synergistic effect of seed extract in 
combination with novobiocin against E. 
coli, S. typhi and K. pneumoniae was better 
than root extract while about of B. anthra-
cis and S. aureus, efficiency of the root ex-
tract was better than seed extract. Further-
more, the observed synergism of root ex-
tract with colistin against E. coli and L. mo-
nocytogenes was better than the seed ex-
tract. Combination of the root extract of P. 
harmala with carbenicillin presented a bet-
ter antibacterial activity against B. an-
thracis and MRSA compared with seed ex-
tract. Meanwhile, the seed and root extract 
in combination with carbenicillin showed a 
relatively weak synergistic activity against 
MRSA. 
 
DISCUSSION 
In recent years, an explosive spread of 
MDR bacterial pathogens has become a se-
rious concern worldwide in terms of public 
health and economic effects. Medicinal 
plants have been shown to be a potential 
source of pharmaceutical natural products. 
The comparison between pharmaceutical 
effect of different parts of a medicinal plant 
can give a good vision for accomplishing 
further study with more efficiency. In this 
study, for the first time we have attempted 
to compare antibacterial activity of the dif-
ferent parts of P. harmala. Each of the used 
parts of P. harmala was collected at the 
best month of collection in terms of their 
secondary metabolite content. Among the 
evaluated different parts of P. harmala, the 
seed and root extract showed the best anti-
bacterial activity against tested clinical bac-
terial pathogens (Figures 1-5). The seed and 
root are known as reservoir parts in plants, 
so, it is very likely that these parts served as 
arsenal of the secondary metabolites with 
antibacterial activity in P. harmala. Based 
on the obtained results, the root extract has 
a better antibacterial activity against Gram 
positive bacteria except L. monocytogenes 
compared with seed extract while about of 
Gram negative bacteria the observed result 
is inverse. Thin Layer Chromatography can 
justify this difference, because the TLC re-
sults for seed and root extract showed that 
these extracts contain several bands with 
different density or even some bands exist 
in one extract that we have not been able to 
find in another one. So, the content of each 
of the constituents and nature of constitu-
ents for these two extracts can be the de-
terminant factors in their antibacterial me-
chanisms. 
 
 
Table 3: Results of the synergistic effects of P. harmala seed and root extracts with antibiotic discs 
 
Bacterial  
species 
NB NB+R NB+S Result CL CL+R CL+S Result CB CB+R CB+S Result 
E. coli 11* 22 24 (Syn) R 26 24 (Syn) -** - - - 
L. monocytogenes 17 24 24 (Syn) R 26 23 (Syn) - - - - 
S. typhi R 25 27 (Syn) - - - - 28 34 34 (Syn) 
B. anthracis 15 28 22 (Syn) - - - - 20 30 26 (Syn) 
K. pneumoniae R 20 30 (Syn) - - - - R 24 32 (Syn) 
MRSA 16 28 25 (Syn) - - - - 24 29 26 (Syn) 
*: Diameter of inhibition zone 
**: Not used 
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Unlike other Gram positive bacteria, L. 
monocytogenes was more resistant to the 
seed extract than the root extract, this result 
may be caused by genetic factors which 
change the affinity of the active phyto-
chemical of root extract to this bacterium or 
also it can be related to the nature and num-
ber of active phytochemicals in the seed 
and root extract of P. harmala. Tested E. 
coli was sensitive to the seed and root ex-
tract, this result is in agreement with the 
document of antibacterial activity of seed 
extract of P. hamala against E. coli sero-
type O1:K1 which has been reported previ-
ously (Arshad et al., 2008). Antibacterial 
effect of active extracts against K. pneumo-
niae especially seed extract was remarkable 
compared with synthetic antibiotic (Figure 
6); this is an encapsulated bacterium that is 
considered as one of the most important 
causative agents of mortality in patients 
with bloodstream infections (Tenover, 
2006). So, these extract can be evaluated 
against other encapsulated clinical bacteria 
such as Streptococcus pneumoniae, which 
in this case forms a rather large capsule as 
its virulence factor and is involved in 60 % 
to 70 % of bacterial pneumonias which 
primarily affect immunocompromised pa-
tients (Talaro, 2009). Figures 8 and 9 re-
vealed that the seed and root extracts re-
mained stable over a wide range of pH and 
temperature, so these extract can also be 
useful in some particular cases. For in-
stance, pH stability is important in the 
treatment of brucellosis, one of the most 
important factors for the treatment of 
brucellosis is that the antibiotic should be 
able to act under acidic condition (pH 5) in 
phagolysosomes of macrophages because 
brucellae grow and replicate in this pH 
value (Akova et al., 1999). Thus, consider-
ing antibacterial activity of the seed and 
root extracts of P. harmala against Br. me-
litensis and their pH resistance ability, this 
plant can be suggested for the treatment of 
brucellosis but in vivo efficacy remains to 
be confirmed. MIC and MBC values (Table 
1) for both seed and root extract against 
MRSA and seed extract against E. coli and 
S. typhi were the same, it is generally held 
that for bactericidal agents, the MIC and 
MBC are often near or equal values; so, it 
can be concluded that these extracts of P. 
harmala have a bactericidal effect on the 
mentioned bacteria (Reuben et al., 2008). 
Nowadays, development of bactericidal 
agents against MRSA as the most important 
causative agent of nosocomial infections is 
valuable so antibacterial activity of seed 
and root extract of P. harmala must be 
tested against MRSA with more details. 
Our results indicate that crude extract of P. 
harmala seed and root exhibited synergistic 
effect in combination with novobiocin, 
colistin and carbenicillin against most im-
portant clinical pathogens. In general, com-
bination therapy such as one resulted from 
synergism between antibiotic and plant ex-
tract can be used to as new choice for 
treatment of infections caused by MDR 
pathogens, to expand antibacterial spec-
trum, to prevent emergence of MDR patho-
gens and to minimize the possible toxic ef-
fects (Aiyegoro et al., 2009a, b). Also, syn-
ergism between plant extract and synthetic 
antibiotics can develop standardization of 
herbal medicine for treatment and preven-
tion of infectious diseases. Unlike the re-
sults that are shown in Figures 1 and 5 
(without combination of extract with anti-
biotic), antibacterial activity of root extract 
associated with colistin against E. coli and 
L. monocytogenes was better than combina-
tion of the seed extract with this antibiotic 
(Table 3). Colistin is an antibiotic that af-
fects the cell membrane of bacteria. So, it is 
likely that the active phytochemicals, which 
exist in root extract, interfere with cell-wall 
petidoglycan synthesis in bacteria more 
than seed extract and finally resulted in in-
creasing of the access of colistin to the cell 
membrane, the outcome of this event is in-
creasing the synergistic effect. On the other 
hand, the active efflux pump in E. coli 
might be responsible for the high levels of 
intrinsic resistance of this bacterium to a 
wide range of antibiotics. So, may these 
extracts interfere with this pump and as-
sumed as resistance modifying agents 
(McKeegan et al., 2002; Coutinho et al., 
2009). So far, several alkaloids with phar-
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maceutical activity including harmine, har-
mane, harmalol, harmaline, vasicine, vasi-
cinon and peganine have been obtained 
from the various parts of this plant (Fathi-
azada et al., 2006; Goel et al., 2009). It has 
been reported that harmane as a highly 
aromatic planar alkaloid exerts its antibac-
terial activity through interchalate with 
DNA (Cowan, 1999), thus, this antibacte-
rial mechanism must be considered for ac-
tive extract of P. harmala.  
 
CONCLUSION 
In conclusion, among evaluated parts of 
P. harmala, seed and root extract were pos-
sessed the most active phytochemicals and 
showed a broad spectrum and strong anti-
bacterial activity against clinical bacterial 
pathogens. The reason of the difference be-
tween antibacterial effect of these two ex-
tracts against Gram positive and negative 
bacteria was justified using TLC, because 
of the difference in nature and content of 
active phytochemicals existing in these ex-
tract. The low values of MIC and MBC for 
these two active extracts against the most 
important of clinical bacterial pathogens 
especially MRSA was valuable. Also, pH 
and temperature stability of seed and root 
extract is important especially for treatment 
of brucellosis. On the other hand, these ac-
tive extracts showed synergism in combina-
tion with novobiocin, carbenicillin and 
colisin against the most important clinical 
pathogens. More studies concerning about 
the molecular basis of this interaction must 
be performed in future. 
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